Neurological Biomarkers Market for Alzheimer's and Parkinson's Diseases to Reach $8.57 Bn, Globally, by 2025 at 10.1% CAGR, Says Allied Market Research
PORTLAND, Oregon, November 22, 2018 /PRNewswire/ --
Increased focus on developing affordable biomarker testing, high demand for non-invasive diagnostic techniques, and rise in adoption in clinical trials would drive the growth of the global neurological biomarkers market for Alzheimer's and Parkinson's disease
Allied Market Research published a report, titled, Neurological Biomarkers Market for Alzheimer's and Parkinson's Diseases - Global Opportunity Analysis and Industry Forecast, 2018-2025. The report presents detailed analyses of the key market trends, drivers & opportunities, market size & forecasts, top investment pockets, and competitive landscape. According to the report, the neurological biomarkers market for Alzheimer's and Parkinson's disease was valued at $3.95 billion in 2017, and is expected to reach $8.57 billion by 2025, registering a CAGR of 10.1% from 2018 to 2025.
(Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg )
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/3555
Introduction of affordable biomarker testing, growing demand for non-invasive diagnostic techniques, and increasing adoption in clinical trials drive the growth of the market. However, strict government regulations and ethical concerns regarding early diagnosis restrict the market growth. On the other hand, increased demand for personalized medicines would create new opportunities for the market.
U.S. neurological Alzheimer's disease biomarkers market to contribute highest revenue by 2025
The neurological Alzheimer's disease biomarkers market in the U.S. contributed more than one-third of the global market revenue in in 2017, owing to significant increase in the number of educational institutes and rise in research & development activities. Asia-Pacific would grow at the fastest CAGR of 12.7% from 2018 to 2025, owing to rise in geriatric population who are suffer from Alzheimer's disease in countries such as India and Japan.
China neurological Parkinson's disease biomarkers market to grow the fastest through 2025
The neurological Parkinson's disease biomarkers market in China would grow at the fastest CAGR of 10.1% from 2018 to 2025 due to the rise in the number of individuals diagnosed with Parkinson's disease and implementation of pharmacological treatment and surgical intervention procedures. However, the U.S. contributed more than one-third of the total market share in 2017, owing to rise in prevalence of Parkinson's disease among geriatric population in the region.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3555
Frontrunners in the industry
The leading market players analyzed in the report include Abbott Laboratories, Proteome Sciences, Myriad RBM, Athena Diagnostics, Thermo Fisher Scientific, Quanterix Corporation, Immunarray Pvt. Ltd., Psynova Neurotech, Diagenic ASA, and Bio-Rad Laboratories. These market players have adopted strategies such as partnerships, collaborations, expansions, joint ventures, and others to strengthen their position in the industry.
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Purchase an enterprise user license and get 1 month complimentary access to our Knowledge Tree subscription. Offer valid till 15th November 2018. (*Terms and Conditions apply)
Get subscription: https://www.alliedmarketresearch.com/checkout/878907
Trending Reports of Medical Devices Market:
Smart Syringe Market - Global Opportunity Analysis and Industry Forecast, 2018 - 2025
3D Medical Imaging Services Market - Global Opportunity Analysis and Industry Forecast, 2017-2023
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Share this article